The emerging approach of the medication represents a significant development in the management of diabetes mellitus type 2. Different to existing therapies, tirzepatide targets dual pathways – GLP-1 and GIP – https://tirzepatide-peptide901326.aioblogs.com/94738948/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment